CleaveNet Enables Scalable and Targeted Protease Substrate Design for Diagnostics and Therapeutics
Scientists from MIT and Microsoft Research present CleaveNet, an AI-based pipeline that merges predictive and generative modeling for end-to-end peptide (short protein) design. By validating the system on matrix metalloproteinases (MMPs), the team demonstrates that AI can uncover novel cleavage motifs, engineer selective substrates, and overcome ever-existing challenges in protease promiscuity. Balancing Efficiency, Selectivity, and…
